Margaret McLoughlin's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Margaret A. McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| Quince Therapeutics Inc | Margaret A. McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 31,613 | 31,613 | - | - | Director Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 08 Aug 2023 | 8,000 | 8,000 (0%) | 0% | 1.2 | 9,840 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 08 Oct 2021 | 1,000 | 1,000 (0%) | 0% | 17 | 17,000 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2021 | 1,000 | 84,911 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 88.93 per share. | 08 Oct 2021 | 1,000 | 0 (0%) | 0% | 88.9 | 88,930 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 6,000 | 85,911 | - | - | Stock Option (right to buy) | |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 16 Aug 2021 | 6,000 | 6,000 (0%) | 0% | 17 | 102,000 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 94.55 per share. | 16 Aug 2021 | 3,056 | 2,944 (0%) | 0% | 94.6 | 288,945 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 96.51 per share. | 16 Aug 2021 | 1,429 | 471 (0%) | 0% | 96.5 | 137,913 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 95.57 per share. | 16 Aug 2021 | 1,044 | 1,900 (0%) | 0% | 95.6 | 99,775 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 97.55 per share. | 16 Aug 2021 | 423 | 48 (0%) | 0% | 97.6 | 41,264 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 98.90 per share. | 16 Aug 2021 | 48 | 0 (0%) | 0% | 98.9 | 4,747 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 55.03 per share. | 28 Jun 2021 | 250 | 100 (0%) | 0% | 55.0 | 13,758 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 55.01 per share. | 28 Jun 2021 | 200 | 350 (0%) | 0% | 55.0 | 11,002 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Sale of securities on an exchange or to another person at price $ 55.73 per share. | 28 Jun 2021 | 100 | 0 (0%) | 0% | 55.7 | 5,573 | Common Stock |
| Quince Therapeutics Inc | Margaret McLoughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 11,029 | 11,029 | - | - | Stock Option (right to buy) |